文献速递神经PETMR

淀粉样蛋白PET的征象与伪影

Signs and Artifacts in Amyloid PET.
PubMed 文献 · Radiographics · 2018-01-01

本文综述淀粉样蛋白PET的适用标准、三种FDA批准的18F标记显像剂特性、算法化判读方法,并展示正常与异常扫描(含MRI对照)及区域征象与常见伪影图谱,以帮助放射科医生更准确判读淀粉样蛋白PET。

要点

  • 淀粉样蛋白PET用于临床特征不典型或早发性轻度认知障碍等疑难痴呆病例,以判断阿尔茨海默痴呆。
  • 18F标记显像剂可体内检测脑淀粉样蛋白沉积,掌握正常与异常脑的常见影像特征有助于准确判读。
  • 淀粉样蛋白PET的影像征象有助于区分某区域正常或异常,熟悉区域征象与常见伪影可减少误判。

核心结论

  • 掌握三种18F标记显像剂在正常与异常脑中的常见影像特征,可使放射科医生更准确地判读淀粉样蛋白PET。
  • 淀粉样蛋白PET的影像征象有助于区分某区域正常或异常,本文明提供区域征象与常见伪影的图谱。
  • 初步数据显示,在符合适用标准的患者中,淀粉样蛋白PET结果改变了临床管理。

研究设计与样本

  • 本文为综述,内容包括淀粉样蛋白PET的适用标准、显像剂特性、判读的算法化方法,以及正常与异常扫描示例(含MRI对照)和区域征象与常见伪影图谱。

诊断标准与关键数值

  • 目前有三种美国FDA批准的18F标记放射性药物,可体内检测脑淀粉样蛋白沉积。
  • 判读采用算法化方法,示例包含正常与异常淀粉样蛋白PET扫描及MRI对照。

临床应用与阅片要点

  • 在临床特征不典型或早发性轻度认知障碍等疑难痴呆表现中,淀粉样蛋白PET是确定阿尔茨海默痴呆诊断的有价值工具。
  • 熟悉三种18F标记显像剂在正常与异常脑中的常见影像特征,有助于更准确判读淀粉样蛋白PET。
  • 判读时可借助算法化方法和区域征象图谱区分某区域正常或异常,并注意识别常见伪影。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Establishing a diagnosis of Alzheimer dementia can be challenging, particularly early in the course of the disease. However, with disease-modifying therapies on the horizon, it is becoming increasingly important to achieve the correct diagnosis as soon as possible. In challenging presentations of dementia, such as patients with clinically atypical features or early-age onset of mild cognitive impairment, amyloid PET is a valuable tool in determining the diagnosis of Alzheimer dementia. Furthermore, preliminary data show that amyloid PET findings alter clinical management in patients who meet the appropriate use criteria. There are currently three U.S. Food and Drug Administration (FDA)-approved fluorine 18 (18F)-labeled radiopharmaceuticals that allow in vivo detection of cerebral amyloid deposition, which is a hallmark pathologic feature of Alzheimer dementia. Knowledge of the common imaging features among these three 18F-labeled radiopharmaceuticals in the normal and abnormal brain will enable the radiologist to more accurately interpret amyloid PET studies. As in other subspecialties of radiology, imaging signs in amyloid PET are helpful to distinguish if a region is normal or abnormal. This article reviews appropriate use criteria for amyloid PET, introduces the properties of the radiopharmaceuticals, explains the algorithmic approach to interpretation with examples of normal and abnormal amyloid PET scans with MRI correlation, and provides an atlas of regional amyloid PET signs and common artifacts. ©RSNA, 2018.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Lundeen TF, Seibyl JP, Covington MF, et al. Signs and Artifacts in Amyloid PET. Radiographics. 2018. PMID: 30422768. doi:10.1148/rg.2018180160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。